BioSig Technologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-29.04	-27.27	-31.36	-52.17	-33.92	Upgrade
Depreciation & Amortization	0.36	0.29	0.2	0.55	0.05	Upgrade
Share-Based Compensation	7.98	4.41	9.5	25.17	15.18	Upgrade
Other Operating Activities	3.39	0.86	-4.74	-0.14	3.21	Upgrade
Operating Cash Flow	-17.31	-21.71	-26.4	-26.6	-15.48	Upgrade
Capital Expenditures	-0.19	-0.17	-0.54	-0.09	-0.29	Upgrade
Acquisitions	0	0	0	0	0	Upgrade
Investing Cash Flow	-0.19	-0.17	-0.54	-0.09	-0.29	Upgrade
Common Stock Issued	15.36	10.35	10.3	27.44	10.01	Upgrade
Other Financing Activities	1.97	0.22	0.03	15.4	13.42	Upgrade
Financing Cash Flow	17.33	10.57	10.33	42.85	23.43	Upgrade
Net Cash Flow	-0.17	-11.3	-16.61	16.16	7.66	Upgrade
Free Cash Flow	-17.5	-21.87	-26.94	-26.69	-15.77	Upgrade
Free Cash Flow Margin	-97216.67%	-7647.90%	-6109.07%	-	-	Upgrade
Free Cash Flow Per Share	-2.38	-5.08	-8.04	-9.56	-7.62	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.